25 studies found for:    "atypical hemolytic-uremic syndrome" OR "Hemolytic-Uremic Syndrome"
Show Display Options
Rank Status Study
21 Completed Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)
Condition: Shiga-like Toxin-producing Escherichia Coli
Intervention: Drug: Eculizumab (Soliris®)
22 Completed Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis
Conditions: Hemolytic Uremic Syndrome;   Hemorrhagic Colitis;   Intestinal Infectious Disease;   Intestinal Infection Due to E. Coli
Intervention: Drug: polyethylene glycol solution for daily bowel lavage.
23 Not yet recruiting Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU
Condition: Hemolytic Uremic Syndrome of Childhood
Interventions: Drug: Eculizumab;   Drug: Placebo
24 Recruiting Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Conditions: Hairy Cell Leukemia (HCL);   Chronic Lymphocytic Leukemia (CLL);   Non-Hodgkins Lymphoma (NHL);   Cutaneous T Cell Lymphoma (CTCL);   Adult T Cell Lymphoma (ATL)
Intervention:
25 Recruiting Early Predictive Factors of Cardiac and Cerebral Involvement in TMA
Conditions: Thrombotic Microangiopathy,;   Thrombotic Thrombocytopenic Purpura,
Intervention: Other: Biological and imaging investigations

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-25) Next Page   
Indicates status has not been verified in more than two years